P2X7 receptor activation induces cell death and microparticle release in murine erythroleukemia cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 9, 2010, Pages 1797-1804

  Constantinescu, Patrick ^a   Wang, Bin ^a   Kovacevic, Kati ^a   Jalilian, Iman ^a   Bosman, Giel J C G M ^b   Wiley, James S ^c   Sluyter, Ronald ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Apoptosis; Macrophage; Microparticle; P2X receptor; Red blood cell

Indexed keywords

2' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; 3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; A 438079; ADENOSINE DERIVATIVE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BIOMALEIMIDE; ETHIDIUM; LIPOCORTIN 5; MALEIMIDE DERIVATIVE; PHOSPHATIDYLSERINE; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; P2RX7 PROTEIN, MOUSE; PURINERGIC P2 RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL SECRETION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; FLOW CYTOMETRY; GROWTH INHIBITION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MEMBRANE MICROPARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; APOPTOSIS; ERYTHROLEUKEMIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; ETHIDIUM; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; PHOSPHATIDYLSERINES; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2X7;

MURINAE;

EID: 77954660508     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.06.002     Document Type: Article

References (50)

1. Burnstock G. Purine and pyrimidine receptors. Cell. Mol. Life Sci. 2007, 64:1471-1483.
2. Khakh B.S., North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006, 442:527-532.
3. Volonte C., D'Ambrosi N. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS J. 2009, 276:318-329.
4. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 2008, 1783:673-694.
5. Jarvis M.F., Khakh B.S. ATP-gated P2X cation channels. Neuropharmacology 2009, 56:208-215.
6. Gever J.R., Cockayne D.A., Dillon M.P., Burnstock G., Ford A.P. Pharmacology of P2X channels. Pflugers Arch. 2006, 452:513-537.
7. Qu Y., Dubyak G.R. P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal. 2009, 5:163-173.
8. 7 receptor: death or life?. Purinergic Signal. 2005, 1:219-227.
9. 7 receptors. Am. J. Physiol. Cell Physiol. 2000, 279:C1189-C1197.
10. 7 function by the inflammatory cytokine IFNgamma in human epithelial cells. Biochim. Biophys. Acta 2009, 1788:1176-1187.
11. 7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol. Endocrinol. 2003, 17:1356-1367.
12. 7 receptor and intracellular pathogens: a continuing struggle. Purinergic Signal. 2009, 5:197-204.
13. 7 in pain and inflammation. Purinergic Signal. 2007, 3:163-169.
14. Grol M.W., Panupinthu N., Korcok J., Sims S.M., Dixon S.J. Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal. 2009, 5:205-221.
15. 7 receptor induces the release of epoxyeicosatrienoic acids. Br. J. Pharmacol. 2007, 151:1033-1040.
16. Skals M., Jorgensen N.R., Leipziger J., Praetorius H.A. α-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4030-4035.
17. 7 receptor. J. Biol. Chem. 2004, 279:44749-44755.
18. 7 receptor: greatly increased function compared to human erythrocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R2090-R2098.
19. 7 receptor activation causes phosphatidylserine exposure in human erythrocytes. Biochem. Biophys. Res. Commun. 2007, 355:169-173.
20. 7 receptor mediates the uptake of organic cations in canine erythrocytes and mononuclear leukocytes: comparison to equivalent human cell type. Purinergic Signal. 2009, 5:385-394.
21. + channels and muscarinic and purinergic receptors identified in human erythroid progenitor cells and red blood cell ghosts. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12730-12734.
22. 13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ. Res. 2005, 96:189-196.
23. Chahwala S.B., Cantley L.C. Extracellular ATP induces ion fluxes and inhibits growth of Friend erythroleukemia cells. J. Biol. Chem. 1984, 259:13717-13722.
24. Tsiftsoglou A.S., Pappas I.S., Vizirianakis I.S. Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol. Ther. 2003, 100:257-290.
25. 7 purinergic receptor: characterization and possible participation in antigen presentation. J. Immunol. 1999, 163:1958-1965.
26. 7 ATP receptor modulates renal cyst development in vitro. Biochem. Biophys. Res. Commun. 2004, 322:434-439.
27. 7 receptors. Exp. Dermatol. 2010, 10.1111/j.1600-0625.2009.01029.x.
28. 7 receptors support rapid prothrombotic responses. Cell. Signal. 2007, 19:855-866.
29. Dale G.L., Remenyi G., Friese P. Quantitation of microparticles released from coated-platelets. J. Thromb. Haemost. 2005, 3:2081-2088.
30. Enjeti A.K., Lincz L., Seldon M. Bio-maleimide as a generic stain for detection and quantitation of microparticles. Int. J. Lab. Hematol. 2008, 30:196-199.
31. Harmar A.J., Hills R.A., Rosser E.M., Jones M., Buneman O.P., Dunbar D.R., Greenhill S.D., Hale V.A., Sharman J.L., Bonner T.I., Catterall W.A., Davenport A.P., Delagrange P., Dollery C.T., Foord S.M., Gutman G.A., Laudet V., Neubig R.R., Ohlstein E.H., Olsen R.W., Peters J., Pin J.P., Ruffolo R.R., Searls D.B., Wright M.W., Spedding M. IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic Acids Res. 2009, 37:D680-D685.
32. Collingridge G.L., Olsen R.W., Peters J., Spedding M. A nomenclature for ligand-gated ion channels. Neuropharmacology 2009, 56:2-5.
33. Lenertz L.Y., Gavala M.L., Hill L.M., Bertics P.J. Cell signaling via the P2X7 nucleotide receptor: linkage to ROS production, gene transcription, and receptor trafficking. Purinergic Signal. 2009, 5:175-187.
34. Pelegrin P., Barroso-Gutierrez C., Surprenant A. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophages. J. Immunol. 2008, 180:7147-7157.
35. Adriouch S., Dubberke G., Diessenbacher P., Rassendren F., Seman M., Haag F., Koch-Nolte F. Probing the expression and function of the P2X7 purinoceptor with antibodies raised by genetic immunization. Cell. Immunol. 2005, 236:72-77.
36. Donnelly-Roberts D.L., Namovic M.T., Han P., Jarvis M.F. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br. J. Pharmacol. 2009, 157:1203-1214.
37. Nelson D.W., Gregg R.J., Kort M.E., Perez-Medrano A., Voight E.A., Wang Y., Grayson G., Namovic M.T., Donnelly-Roberts D.L., Niforatos W., Honore P., Jarvis M.F., Faltynek C.R., Carroll W.A. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. J. Med. Chem. 2006, 49:3659-3666.
38. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., Green D.R., Hengartner M., Knight R.A., Kumar S., Lipton S.A., Malorni W., Nuñez G., Peter M.E., Tschopp J., Yuan J., Piacentini M., Zhivotovsky B., Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16:3-11.
39. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., Egerton J., Murfin M., Richardson J., Peck W.L., Grahames C.B., Casula M.A., Yiangou Y., Birch R., Anand P., Buell G.N. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114:386-396.
40. Labasi J.M., Petrushova N., Donovan C., McCurdy S., Lira P., Payette M.M., Brissette W., Wicks J.R., Audoly L., Gabel C.A. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 2002, 168:6436-6445.
41. Gorodeski G.I. P2X7-mediated chemoprevention of epithelial cancers. Expert Opin. Ther. Targets 2009, 13:1313-1332.
42. Baroni M., Pizzirani C., Pinotti M., Ferrari D., Adinolfi E., Calzavarini S., Caruso P., Bernardi F., Di Virgilio F. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J. 2007, 21:1926-1933.
43. Bianco F., Pravettoni E., Colombo A., Schenk U., Moller T., Matteoli M., Verderio C. Astrocyte-derived ATP induces vesicle shedding and IL-1beta release from microglia. J. Immunol. 2005, 174:7268-7277.
44. Qu Y., Ramachandra L., Mohr S., Franchi L., Harding C.V., Nunez G., Dubyak G.R. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J. Immunol. 2009, 182:5052-5062.
45. Wilson H.L., Francis S.E., Dower S.K., Crossman D.C. Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation. J. Immunol. 2004, 173:1202-1208.
46. Enjeti A.K., Lincz L.F., Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Semin. Thromb. Hemost. 2007, 33:771-779.
47. Blanc L., De Gassart A., Geminard C., Bette-Bobillo P., Vidal M. Exosome release by reticulocytes-an integral part of the red cell differentiation system. Blood Cells Mol. Dis. 2005, 35:21-26.
48. Greenwalt T.J. The how and why of exocytic vesicles. Transfusion 2006, 46:143-152.
49. Bosman G.J., Werre J.M., Willekens F.L.A., Novotny M.J. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus. Med. 2008, 18:335-347.
50. Willekens F.L., Werre J.M., Groenen-Döpp Y.A., Roerdinkholder-Stoelwinder B., de Pauw B., Bosman G.J. Erythrocyte vesiculation: a self-protective mechanism?. Br. J. Haematol. 2008, 141:549-556.